unnamed (1).jpg
Screen Shot 2018-09-07 at 21.49.10.png
Aril sizes.png

Aril® is a room temperature stable allograft derived from human placental tissue collected from consenting donors. Post-decellularization & stabilization, Aril® is packaged in a double pouch packaging system and subjected to low dose gamma irradiation. Aril® is an allograft tissue intended for homologous use regulated by 21 CFR Part 1271 and Section 361 of the PHS Act.

Aril® is configured as a precision cut single layer of amnion shaped as an ellipse or disc. The configuration was selected and designed to maximize clinical usable surface area and limit necessary pre-operative manipulation of the graft. Seed Biotech, Inc. has shown a greater than 95% reduction in DNA using their proprietary decellularization process. As a single layer of amnion, it is not necessary to emboss Aril® as there is no side-specific orientation to the graft. 


This allograft is intended for homologous use and can be used in a variety of orthopedic, surgical, ophthalmology, spinal and wound covering applications. For specific instructions on the use and risks of Aril® products please refer to the product insert instructions for use for information.

Clinical Advantage Overview:

Aril® offers the clinical advantages of being an acellular precision cut graft designed and produced under industry expert guidance for optimal safety, efficacy, and clinical practicality.


I wanted to take a minute and write about my experience with your tissue (Aril). I was a bit skeptical, given that your company is the new kid on the block. After 4 applications of your tissue, I am a convert! I’ve been using amniotic membranes for a long time, but your product is just as good, if not better. I will be spreading the word! 
— Inna Ozerov, MD, Miami Eye Institute
I’ve been incredibly satisfied with the Aril product and have recommended many colleagues to utilize in their practices.
— David A. Goldman, MD, Goldman Eye